Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
12 08 2019
Historique:
received: 16 04 2019
accepted: 22 07 2019
entrez: 14 8 2019
pubmed: 14 8 2019
medline: 11 11 2020
Statut: epublish

Résumé

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a genetically heterogeneous renal disorder leading to progressive loss of renal function. ADTKD-REN is due to rare mutations in renin, all localized in the protein leader peptide and affecting its co-translational insertion in the endoplasmic reticulum (ER). Through exome sequencing in an adult-onset ADTKD family we identified a new renin variant, p.L381P, mapping in the mature protein. To assess its pathogenicity, we combined genetic data, computational and predictive analysis and functional studies. The L381P substitution affects an evolutionary conserved residue, co-segregates with renal disease, is not found in population databases and is predicted to be deleterious by in silico tools and by structural modelling. Expression of the L381P variant leads to its ER retention and induction of the Unfolded Protein Response in cell models and to defective pronephros development in zebrafish. Our work shows that REN mutations outside of renin leader peptide can cause ADTKD and delineates an adult form of ADTKD-REN, a condition which has usually its onset in childhood. This has implications for the molecular diagnosis and the estimated prevalence of the disease and points at ER homeostasis as a common pathway affected in ADTKD-REN, and possibly more generally in ADTKD.

Identifiants

pubmed: 31406136
doi: 10.1038/s41598-019-48014-6
pii: 10.1038/s41598-019-48014-6
pmc: PMC6691008
doi:

Substances chimiques

Renin EC 3.4.23.15

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11601

Références

Am J Hum Genet. 2016 Jul 7;99(1):174-87
pubmed: 27392076
Am J Kidney Dis. 2011 Nov;58(5):821-5
pubmed: 21903317
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
IUCrJ. 2018 Aug 08;5(Pt 5):585-594
pubmed: 30224962
Am J Hum Genet. 2009 Aug;85(2):204-13
pubmed: 19664745
Sci Rep. 2017 Aug 7;7(1):7383
pubmed: 28785050
J Mol Biol. 2012 Aug 3;421(1):100-11
pubmed: 22575890
J Clin Invest. 2018 Jan 2;128(1):64-73
pubmed: 29293089
Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9948-9953
pubmed: 28851829
Biotechniques. 2000 Jun;28(6):1102, 1104
pubmed: 10868275
PLoS One. 2017 Apr 24;12(4):e0175970
pubmed: 28437467
Physiol Rev. 2006 Jul;86(3):747-803
pubmed: 16816138
Sci Rep. 2018 Jul 5;8(1):10189
pubmed: 29976931
Adv Chronic Kidney Dis. 2017 Mar;24(2):86-93
pubmed: 28284384
Proc Natl Acad Sci U S A. 1987 Nov;84(22):7837-40
pubmed: 3317396
BMC Nephrol. 2018 Oct 30;19(1):301
pubmed: 30376835
Compr Physiol. 2014 Jul;4(3):1201-28
pubmed: 24944035
Nucleic Acids Res. 2017 Jul 3;45(W1):W229-W235
pubmed: 28525590
PLoS One. 2017 Nov 16;12(11):e0186769
pubmed: 29145399
Int J Cancer. 2018 Oct 1;143(7):1706-1719
pubmed: 29672841
Mol Med. 2011;17(11-12):1295-305
pubmed: 21863214
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W452-7
pubmed: 22689647
Mol Cell. 2000 Nov;6(5):1099-108
pubmed: 11106749
J Biol Chem. 2014 Jun 6;289(23):16290-302
pubmed: 24770419
Am J Hum Genet. 2016 Jun 2;98(6):1077-1081
pubmed: 27236918
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Nephrol. 2010 Dec;74(6):411-22
pubmed: 21084044
Semin Nephrol. 2010 Jul;30(4):366-73
pubmed: 20807609
J Clin Invest. 2017 Nov 1;127(11):3954-3969
pubmed: 28990932
Nat Genet. 2005 Sep;37(9):964-8
pubmed: 16116425
Nat Methods. 2014 Apr;11(4):361-2
pubmed: 24681721
J Am Soc Nephrol. 2018 Sep;29(9):2298-2309
pubmed: 30049680
J Biol Chem. 2000 Sep 1;275(35):27013-20
pubmed: 10856300
Mol Cell Endocrinol. 2014 Jul 5;392(1-2):60-72
pubmed: 24796658
Nat Methods. 2010 Apr;7(4):248-9
pubmed: 20354512
Dis Model Mech. 2017 Jun 1;10(6):773-786
pubmed: 28325753
BMC Nephrol. 2017 Jul 12;18(1):234
pubmed: 28701203
Sci Rep. 2017 Feb 21;7:42970
pubmed: 28220896

Auteurs

Céline Schaeffer (C)

Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Claudia Izzi (C)

Division of Nephrology and Dialysis, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia and Montichiari Hospital, Brescia, Italy.
Prenatal Diagnosis Unit, Department of Obstetrics and Gynecology, ASST Spedali Civili, Brescia, Italy.

Andrea Vettori (A)

Department of Biology, University of Padova, Padova, Italy.
Department of Biotechnology, University of Verona, Verona, Italy.

Elena Pasqualetto (E)

Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Davide Cittaro (D)

Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Dejan Lazarevic (D)

Center for Translational Genomics and Bioinformatics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Gianluca Caridi (G)

Laboratory of Molecular Nephrology, Istituto Giannina Gaslini IRCCS, Genoa, Italy.

Barbara Gnutti (B)

Laboratory of Medical Genetics, Department of Pathology, ASST Spedali Civili, Brescia, Italy.

Cinzia Mazza (C)

Laboratory of Medical Genetics, Department of Pathology, ASST Spedali Civili, Brescia, Italy.

Luca Jovine (L)

Department of Biosciences and Nutrition & Center for Innovative Medicine, Karolinska Institutet, Huddinge, Sweden.

Francesco Scolari (F)

Division of Nephrology and Dialysis, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia and Montichiari Hospital, Brescia, Italy.

Luca Rampoldi (L)

Molecular Genetics of Renal Disorders, Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy. rampoldi.luca@hsr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH